Fenofibrate: A Review of its Use in Primary Dyslipidaemia, the Metabolic Syndrome and Type 2 Diabetes Mellitus

Author： Keating Gillian M.   Croom Katherine F.  

Publisher： Adis International

ISSN： 0012-6667

Source： Drugs, Vol.67, Iss.1, 2007-01, pp. : 121-153

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Fenofibrate: A Review of its Use in Dyslipidaemia

By McKeage Kate   Keating Gillian M.  

Drugs, Vol. 71, Iss. 14, 2011-10 ,pp. : 1917-1946

Adis International

Access to resources Recommend Favorite

Fenofibrate: A Review of its Lipid-Modifying Effects in Dyslipidemia and its Vascular Effects in Type 2 Diabetes Mellitus

By Keating Gillian M.  

American Journal of Cardiovascular Drugs, Vol. 11, Iss. 4, 2011-08 ,pp. : 227-247

Adis International

Access to resources Recommend Favorite

Dyslipidaemia in the metabolic syndrome and type 2 diabetes: pathogenesis, priorities, pharmacotherapies

By Chan Dick C   Watts Gerald F  

Expert Opinion on Pharmacotherapy, Vol. 12, Iss. 1, 2011-01 ,pp. : 13-30

Informa Healthcare

Access to resources Recommend Favorite

Atorvastatin: A Review of its Use in the Primary Prevention of Cardiovascular Events in Patients with Type 2 Diabetes Mellitus

By Croom Katherine F.   Plosker Greg L.  

Drugs, Vol. 65, Iss. 1, 2005-01 ,pp. : 137-152

Adis International

Access to resources Recommend Favorite

Troglitazone: A Review of its Use in the Management of Type 2 Diabetes Mellitus

By Plosker G.L.   Faulds D.  

Drugs, Vol. 57, Iss. 3, 1999-03 ,pp. : 409-438

Adis International

Access to resources Recommend Favorite